187 related articles for article (PubMed ID: 18280332)
1. New viral vaccines for dermatologic disease.
Urman CO; Gottlieb AB
J Am Acad Dermatol; 2008 Mar; 58(3):361-70. PubMed ID: 18280332
[TBL] [Abstract][Full Text] [Related]
2. Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection.
Brisson M; Van de Velde N; De Wals P; Boily MC
CMAJ; 2007 Aug; 177(5):464-8. PubMed ID: 17709404
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of genital HPV infection among long-term monogamous partners of women with cervical dysplasia or genital warts-Another reason for HPV vaccination of boys.
Rob F; Tachezy R; Pichlík T; Rob L; Kružicová Z; Hamšíková E; Šmahelová J; Hercogová J
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723194
[TBL] [Abstract][Full Text] [Related]
4. Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.
Van de Velde N; Boily MC; Drolet M; Franco EL; Mayrand MH; Kliewer EV; Coutlée F; Laprise JF; Malagón T; Brisson M
J Natl Cancer Inst; 2012 Nov; 104(22):1712-23. PubMed ID: 23104323
[TBL] [Abstract][Full Text] [Related]
5. HPV vaccines: their pathology-based discovery, benefits, and adverse effects.
Nicol AF; de Andrade CV; Russomano FB; Rodrigues LS; Oliveira NS; Provance DW; Nuovo GJ
Ann Diagn Pathol; 2015 Dec; 19(6):418-22. PubMed ID: 26321154
[TBL] [Abstract][Full Text] [Related]
6. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine.
Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911
[TBL] [Abstract][Full Text] [Related]
7. Currently approved prophylactic HPV vaccines.
Harper DM
Expert Rev Vaccines; 2009 Dec; 8(12):1663-79. PubMed ID: 19943762
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus: clinical manifestations and prevention.
Juckett G; Hartman-Adams H
Am Fam Physician; 2010 Nov; 82(10):1209-13. PubMed ID: 21121531
[TBL] [Abstract][Full Text] [Related]
9. Trends in Genital Warts in the Era of Human Papillomavirus Vaccination.
Calo WA; Brewer NT
Sex Transm Dis; 2015 Dec; 42(12):669-70. PubMed ID: 26560967
[No Abstract] [Full Text] [Related]
10. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy.
Brotherton JM; Kaldor JM; Garland SM
Sex Health; 2010 Sep; 7(3):310-9. PubMed ID: 20719220
[TBL] [Abstract][Full Text] [Related]
11. Estimates of the timing of reductions in genital warts and high grade cervical intraepithelial neoplasia after onset of human papillomavirus (HPV) vaccination in the United States.
Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
Vaccine; 2013 Aug; 31(37):3899-905. PubMed ID: 23820080
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel: accounting for CIN1 and genital warts in addition to CIN2/3 and cervical cancer.
Shavit O; Raz R; Stein M; Chodick G; Schejter E; Ben-David Y; Cohen R; Arbel D; Shalev V
Appl Health Econ Health Policy; 2012 Mar; 10(2):87-97. PubMed ID: 22201263
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccines and vaccine implementation.
de Sanjosé S; Alemany L; Castellsagué X; Bosch FX
Womens Health (Lond); 2008 Nov; 4(6):595-604. PubMed ID: 19072462
[TBL] [Abstract][Full Text] [Related]
14. [Expected impact of a quadrivalent HPV vaccine in France].
Riethmuller D; Prétet JL; Denis F; Aubin F; Pradat P; Clavel C; Dachez R; Gondry J; Carcopino X; Mougin C
J Gynecol Obstet Biol Reprod (Paris); 2009 Sep; 38(5):389-95. PubMed ID: 19481365
[TBL] [Abstract][Full Text] [Related]
15. Population impact of HPV vaccines: summary of early evidence.
Hariri S; Markowitz LE; Dunne EF; Unger ER
J Adolesc Health; 2013 Dec; 53(6):679-82. PubMed ID: 24263069
[TBL] [Abstract][Full Text] [Related]
16. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial.
; Dillner J; Kjaer SK; Wheeler CM; Sigurdsson K; Iversen OE; Hernandez-Avila M; Perez G; Brown DR; Koutsky LA; Tay EH; García P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Lehtinen M; Steben M; Bosch FX; Joura EA; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Maansson R; Lu S; Vuocolo S; Hesley TM; Barr E; Haupt R
BMJ; 2010 Jul; 341():c3493. PubMed ID: 20647284
[TBL] [Abstract][Full Text] [Related]
17. Prevention of human papilloma virus infection with vaccines.
Azam F; Shams-ul-Islam M
J Pak Med Assoc; 2010 Aug; 60(8):676-81. PubMed ID: 20726203
[TBL] [Abstract][Full Text] [Related]
18. [Human papillomavirus (HPV) vaccines--a new method for the prevention of cervical cancer].
Friedek DA; Ekiel AM; Martirosian G
Wiad Lek; 2007; 60(1-2):34-8. PubMed ID: 17607966
[TBL] [Abstract][Full Text] [Related]
19. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
[TBL] [Abstract][Full Text] [Related]
20. Human papilloma virus vaccines and their role in cancer prevention.
Jones RW; Coughlan EP; Reid JS; Sykes P; Watson PD; Cook C
N Z Med J; 2007 Nov; 120(1266):U2829. PubMed ID: 18264198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
